Study of 6,750 healthy children to include infants as young as 6 months
By Art Moore
Published March 17, 2021 at 7:30pm
While polls have indicated about one-third of adults are skeptical of the experimental COVID-19 vaccines, Moderna announced it has given its first doses to children under age 12, including babies as young as 6 months.
The study is expected to enroll 6,750 healthy children in the United States and Canada, the New York Post reported.
Moderna is among three manufacturers with a vaccine approved for use in the U.S. However, Moderna’s and Johnson & Johnson’s are authorized only for adults 18 and older. Pfizer’s shot can be administered to people 16 and older.
The Post said Moderna has not issued a timeline for the trial.
The vaccines, through President Trump’s Operation Warp Speed, were developed and brought to market in just one year, while the normal process takes five to 10 years. On Monday, amid reports of dangerous blood clots in some recepients, Germany, France, Italy and Spain became the latest nations to suspend use of AstraZeneca’s COVID-19 vaccine.
White House coronavirus adviser Dr. Anthony Fauci has said it would be “months” before enough data could be collected before allowing children to be vaccinated.
READ MORE HERE: Moderna begins testing COVID-19 vaccine on babies (wnd.com)